We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current SKIN market cap is 414.72M. The company's latest EPS is USD -0.8111 and P/E is -15.40.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Total Revenue | 88.79M | 98.13M | 86.28M | 117.48M | 97.41M |
Operating Income | -4.14M | -3.77M | -17.31M | -13.15M | -82.1M |
Net Income | 131k | 3.82M | -22.29M | 5.39M | -78.57M |
Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 260.09M | 365.88M | 397.99M |
Operating Income | -1.21M | -36.64M | -24.28M | -130.92M |
Net Income | -1.11M | -375.11M | 44.38M | -100.12M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Total Assets | 1.1B | 1.01B | 994.95M | 1.01B | 973.07M |
Total Liabilities | 846.89M | 837.43M | 847.29M | 845.63M | 883.12M |
Total Equity | 257.91M | 171.48M | 147.66M | 161.84M | 89.96M |
Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 464M | 1.22B | 1.01B | 929.11M |
Total Liabilities | 16.87M | 916.51M | 837.43M | 869.72M |
Total Equity | 5M | 302.3M | 171.48M | 59.39M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Operating | -101.21M | -106.6M | -13.01M | 8.96M | 26.92M |
Investing | -16.05M | -18.87M | -21.68M | -24.9M | -29.34M |
Financing | -102.76M | -205.24M | -2.2M | -3.74M | -6.09M |
Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -1.09M | -28.36M | -106.6M | 21.75M |
Investing | -460M | -37.73M | -18.87M | -31.51M |
Financing | 464.36M | 959.04M | -205.24M | -37.45M |
Market Cap | 414.72M |
Price to Earnings Ratio | -15.40 |
Price to Sales Ratio | 3.87 |
Price to Cash Ratio | 2.95 |
Price to Book Ratio | 25.96 |
Dividend Yield | - |
Shares Outstanding | 123.43M |
Average Volume (1 week) | 1.47M |
Average Volume (1 Month) | 1.62M |
52 Week Change | -66.99% |
52 Week High | 11.165 |
52 Week Low | 1.35 |
Spread (Intraday) | 2.64 (66%) |
Company Name | Beauth Health Company |
Address |
1819 west avenue bay 2 miami beach, florida 33139 |
Website | https:// |
Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions